Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005777 | peroxisome | 6 | 1 |
GO:0020015 | glycosome | 7 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: Q4Q5C8
Term | Name | Level | Count |
---|---|---|---|
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 8 | 3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7 | 3 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006401 | RNA catabolic process | 5 | 3 |
GO:0006402 | mRNA catabolic process | 6 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009056 | catabolic process | 2 | 3 |
GO:0009057 | macromolecule catabolic process | 4 | 3 |
GO:0009892 | negative regulation of metabolic process | 4 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0010468 | regulation of gene expression | 5 | 3 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 3 |
GO:0010629 | negative regulation of gene expression | 6 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0016071 | mRNA metabolic process | 6 | 3 |
GO:0019222 | regulation of metabolic process | 3 | 3 |
GO:0019439 | aromatic compound catabolic process | 4 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0044248 | cellular catabolic process | 3 | 3 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 3 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 3 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0046700 | heterocycle catabolic process | 4 | 3 |
GO:0048519 | negative regulation of biological process | 3 | 3 |
GO:0050789 | regulation of biological process | 2 | 3 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 3 |
GO:0065007 | biological regulation | 1 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:0110154 | RNA decapping | 6 | 3 |
GO:0110156 | methylguanosine-cap decapping | 7 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 3 |
GO:1901575 | organic substance catabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0016462 | pyrophosphatase activity | 5 | 11 |
GO:0016787 | hydrolase activity | 2 | 16 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 11 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 11 |
GO:0050072 | obsolete m7G(5')pppN diphosphatase activity | 6 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.424 |
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.325 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.294 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.422 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.414 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.417 |
CLV_PCSK_PC1ET2_1 | 175 | 177 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.403 |
DOC_MAPK_gen_1 | 114 | 123 | PF00069 | 0.470 |
DOC_MAPK_gen_1 | 13 | 20 | PF00069 | 0.283 |
DOC_MAPK_MEF2A_6 | 13 | 20 | PF00069 | 0.339 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.452 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.199 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.295 |
DOC_USP7_UBL2_3 | 116 | 120 | PF12436 | 0.399 |
DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.360 |
LIG_14-3-3_CanoR_1 | 13 | 17 | PF00244 | 0.279 |
LIG_14-3-3_CanoR_1 | 150 | 159 | PF00244 | 0.543 |
LIG_14-3-3_CanoR_1 | 41 | 45 | PF00244 | 0.437 |
LIG_Actin_WH2_2 | 127 | 143 | PF00022 | 0.244 |
LIG_deltaCOP1_diTrp_1 | 155 | 161 | PF00928 | 0.260 |
LIG_eIF4E_1 | 129 | 135 | PF01652 | 0.225 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.425 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.194 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.389 |
LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 127 | 132 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 154 | 159 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 61 | 66 | PF02991 | 0.309 |
LIG_LYPXL_S_1 | 128 | 132 | PF13949 | 0.317 |
LIG_LYPXL_yS_3 | 129 | 132 | PF13949 | 0.318 |
LIG_MYND_3 | 191 | 195 | PF01753 | 0.281 |
LIG_PDZ_Class_1 | 210 | 215 | PF00595 | 0.711 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.355 |
LIG_TRAF2_1 | 124 | 127 | PF00917 | 0.338 |
LIG_TRAF2_1 | 62 | 65 | PF00917 | 0.427 |
LIG_UBA3_1 | 131 | 139 | PF00899 | 0.285 |
LIG_WW_3 | 171 | 175 | PF00397 | 0.287 |
MOD_CDC14_SPxK_1 | 53 | 56 | PF00782 | 0.190 |
MOD_CDK_SPxK_1 | 50 | 56 | PF00069 | 0.190 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.565 |
MOD_CK2_1 | 121 | 127 | PF00069 | 0.433 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.348 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.505 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.457 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.327 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.335 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.414 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.365 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.421 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.297 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.368 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.445 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.380 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.290 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.376 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.190 |
MOD_Plk_1 | 72 | 78 | PF00069 | 0.460 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.459 |
MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.360 |
MOD_SUMO_for_1 | 135 | 138 | PF00179 | 0.538 |
TRG_DiLeu_BaEn_2 | 22 | 28 | PF01217 | 0.392 |
TRG_DiLeu_BaLyEn_6 | 189 | 194 | PF01217 | 0.381 |
TRG_DiLeu_LyEn_5 | 127 | 132 | PF01217 | 0.251 |
TRG_ENDOCYTIC_2 | 129 | 132 | PF00928 | 0.318 |
TRG_ER_diArg_1 | 12 | 14 | PF00400 | 0.309 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.308 |
TRG_NLS_MonoExtN_4 | 172 | 178 | PF00514 | 0.297 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P9K0 | Leptomonas seymouri | 50% | 91% |
A0A1X0P292 | Trypanosomatidae | 37% | 71% |
A0A3Q8IFW7 | Leishmania donovani | 50% | 88% |
A0A3Q8IL17 | Leishmania donovani | 84% | 82% |
A0A422P4Y4 | Trypanosoma rangeli | 39% | 90% |
A4HKE1 | Leishmania braziliensis | 70% | 93% |
A4I7W9 | Leishmania infantum | 50% | 88% |
C9ZPX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
C9ZQT5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 71% |
E9B2T0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 49% | 88% |
Q4Q5C7 | Leishmania major | 48% | 100% |
Q4QJJ4 | Leishmania major | 30% | 100% |
V5BU70 | Trypanosoma cruzi | 42% | 84% |
V5DQQ5 | Trypanosoma cruzi | 42% | 84% |